Evidence map›Paper›PMID 39285166›Full record

ArticleHuman genome variation2024

Novel MLH1 nonsense variant in a patient with suspected Lynch syndrome.

Nobue Takaiso, Issei Imoto, Toshihiko Matsumoto, Akiyo Yoshimura

Abstract read
In one paragraph

Article in Human genome variation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Lynch syndrome withOpen life sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nobue Takaiso *Risk Assessment Unit, Aichi Cancer Center Hospital, Nagoya, Japan.
Issei Imoto *Risk Assessment Unit, Aichi Cancer Center Hospital, Nagoya, Japan. iimoto@aichi-cc.jp.ORCID http://orcid.org/0000-0002-4150-7938
Toshihiko MatsumotoDepartment of Medical Oncology, Ichinomiyanishi Hospital, Ichinomiya, Japan.
Akiyo YoshimuraRisk Assessment Unit, Aichi Cancer Center Hospital, Nagoya, Japan.

Funding

Japan Agency for Medical Research and Development (AMED) JP22kk0305020Japan Agency for Medical Research and Development (AMED) JP23ck0106872
6 · The paper itself

Abstract

Loss-of-function germline variants of MLH1 cause Lynch syndrome. Here, we present the case of a 43-year-old male patient diagnosed with cecal and transverse colon adenocarcinomas. The characteristics of the case met the revised Bethesda guidelines, and the tumors demonstrated a high frequency of microsatellite instability. Genetic testing for mismatch repair genes (indicative of Lynch syndrome) revealed a novel heterozygous germline pathogenic variant, NM_000249.4:c.856A>T/NP_000240.1:p.(Lys286Ter), in MLH1.

Identifiers

PMID39285166
PMCPMC11405935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.